
Jalindar Dagadu Padwal
About Jalindar Dagadu Padwal
Data last updated:
Jalindar Dagadu Padwal is a Director at Atharva Biopharma Private Limited (since 2019), Designated Partner at Aes Pharma Llp (since 2026) and Director at Bioquant Pharmaceuticals Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma. The largest current company by reported revenue is Atharva Biopharma Private Limited at ₹7.23 Cr (FY 2025). Earlier, Jalindar Dagadu Padwal was a Director at Atharva Biopharma And Research Private Limited (from 2019) and Director at Nova Beverages Private Limited (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Nov 2019 | 2019 | ₹7.23 Cr (FY 2025) | Active | |
| Designated Partner | 21 Sep 2026 | 2026 | Active | ||
| Director | 23 Dec 2025 | 2025 | Active | ||
| Director | 20 Mar 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Jul 2019 | 2019 | Strike Off | ||
| Director | 07 Jan 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jalindar Dagadu Padwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mansing Nanasaheb Pachundkar | 02140459 | Atharva Biopharma Private Limited | Director |
| Mohan Raghunath Jadhav | 02046668 | Atharva Biopharma Private Limited | Additional Director |
| Sanjaykumar Harishchandra Mache | 06516292 | Atharva Biopharma Private Limited | Additional Director |
| Sharad Raosaheb Sable | 07315650 | Aes Pharma Llp | Designated Partner |
| Niketan Fakkad Shete | 11445000 | Bioquant Pharmaceuticals Private Limited | Director |
| Ankush Ramchandra Kshirsagar | 10637943 | Neowise Life Sciences Private Limited | Director |
| Radish Rajan Nair | 08940983 | Neowise Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jalindar Dagadu Padwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jalindar Dagadu Padwal
Jalindar Dagadu Padwal currently holds 4 directorships: Atharva Biopharma Private Limited (Director, since 25 Nov 2019, revenue ₹7.23 Cr (FY 2025)); Aes Pharma Llp (Designated Partner, since 21 Sep 2026); Bioquant Pharmaceuticals Private Limited (Director, since 23 Dec 2025); Neowise Life Sciences Private Limited (Director, since 20 Mar 2017).
Jalindar Dagadu Padwal was first appointed on 07 Jan 2016 as Director at Nova Beverages Private Limited. The most recent appointment on record is 21 Sep 2026 at Aes Pharma Llp.
Jalindar Dagadu Padwal held 2 earlier board appointments: Atharva Biopharma And Research Private Limited (Director, from 18 Jul 2019); Nova Beverages Private Limited (Director, from 07 Jan 2016).
The current boards of Jalindar Dagadu Padwal's companies include Mansing Nanasaheb Pachundkar (Atharva Biopharma Private Limited), Mohan Raghunath Jadhav (Atharva Biopharma Private Limited), Sanjaykumar Harishchandra Mache (Atharva Biopharma Private Limited), Sharad Raosaheb Sable (Aes Pharma Llp), Niketan Fakkad Shete (Bioquant Pharmaceuticals Private Limited), Ankush Ramchandra Kshirsagar (Neowise Life Sciences Private Limited), among others.